跳至主要内容
临床试验/CTRI/2025/01/078845
CTRI/2025/01/078845尚未招募2 期

A Randomized controlled clinical study to evaluate the efficacy of Ayurvedic formulation formulation in the management of primary hypertension

Dr Archi Saraf1 个研究点 分布在 1 个国家目标入组 62 人开始时间: 2025年3月3日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
62
试验地点
1
主要终点
Reduction in Blood pressure

研究概览

简要总结

A Randomized Comparative Clinical Study to Evaluate the Efficacy of Ayurvedic formulation in the management of primary Hypertension

25 gm powder of ayurvedic formulation will be given to form decoction in 200 ml of water till 1/4th reduction will administered twice a day (12.5 gm in morning and 12.5 gm in evening ) for 14 days with follow ups of 7th and 14th day

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Systolic Blood pressure.
  • less than 180 mm of Hg more than and equal to 140 mm of Hg Diastolic Blood pressure.
  • less than 110 mm of Hg more than and equal to 90 mm of Hg newly diagnosed patients.

排除标准

  • Secondary hypertension Alcoholic and Drug abusers pregnant and lactating women.

结局指标

主要结局

Reduction in Blood pressure

时间窗: 14 days with follow ups of 7th and 14th day

次要结局

  • Reduction in symptoms of primary hypertension like headache, giddiness, fatigue, insomnia, perspiration, palpitation(14 days with follow ups of 7th and 14th day)

研究者

发起方
Dr Archi Saraf
申办方类型
Other [[self]]
责任方
Principal Investigator
主要研究者

Dr Archi Saraf

Dr. D. Y. Patil college of Ayurveda and Research centre, Pimpri, PUNE

研究点 (1)

Loading locations...

相似试验